GLAM
KITE

Gardner Lewis Asset Management’s Kite Pharma, Inc. KITE Stock Holding History

Gardner Lewis Asset Management’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-773,817
Closed -$139M – 122
2017
Q3 		$139M Buy
+773,817
New +$108M 8.89% 3

Gardner Lewis Asset Management's KITE Position: Q4 2017 in Review

Gardner Lewis Asset Management sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 773,817 shares — an estimated $139M sold.

Gardner Lewis Asset Management first reported a position in KITE in Q3 2017 and held it in 1 quarter. The position peaked at $139M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • Gardner Lewis Asset Management reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • Gardner Lewis Asset Management sold 773,817 Kite Pharma, Inc. shares in Q4 2017, an estimated $139M.
  • Gardner Lewis Asset Management first reported a position in Kite Pharma, Inc. in Q3 2017 and held it in 1 quarter.
  • Gardner Lewis Asset Management's Kite Pharma, Inc. position peaked at $139M in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Gardner Lewis Asset Management's 13F filing for Q4 2017, filed 14 Feb 2018.